Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Affinity and Avidity01:41

Affinity and Avidity

39.8K
Overview
39.8K
Affinity Chromatography01:03

Affinity Chromatography

3.3K
Affinity chromatography is a powerful technique extensively utilized for separating and purifying specific biomolecules from complex mixtures. It capitalizes on the highly selective binding between an analyte and its counterpart, such as antibody-antigen interactions. The counterpart is immobilized on the stationary phase, forming an affinity column. The stationary phase typically consists of solid support, such as agarose or porous glass beads, immobilizing the affinity ligand. The mobile...
3.3K
Antibody Structure01:10

Antibody Structure

66.6K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
66.6K
Hybridoma Technology01:31

Hybridoma Technology

18.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
18.0K
Antibody Actions01:26

Antibody Actions

3.2K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
3.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Novel Vitreous Substitutes in Animal and Human Models: A Systematic Review.

BioMed research international·2026
Same author

Quantitative prediction of siRNA complexation by ionizable drugs enables their codelivery in nanoparticles.

Science advances·2026
Same author

Dexime: A Selectively Enzyme-Degradable Hydrogel for Protein Therapeutic Release.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

From memorization to generalization: Why physics will improve machine learning -based prediction of protein complexes.

Current opinion in structural biology·2026
Same author

Bias in the AlphaFold3 prediction of ligand-induced domain motion in enzymes.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Discovery of pyrrolopyrimidinone inhibitors of the BCL6-SMRT corepressor interaction.

Bioorganic & medicinal chemistry·2026

相关实验视频

Updated: Mar 7, 2026

Activated Cross-linked Agarose for the Rapid Development of Affinity Chromatography Resins - Antibody Capture as a Case Study
07:53

Activated Cross-linked Agarose for the Rapid Development of Affinity Chromatography Resins - Antibody Capture as a Case Study

Published on: August 16, 2019

9.9K

一个可定制的抗体输送策略,使用Fc-Affinity Ligands.

Daniela Isaacs-Bernal1,2, Noor E Bahsoun1,2, Lia Huo2,3

  • 1Department of Chemical Engineering and Applied Chemistry, University of Toronto, 200 College Street, Toronto, Ontario M5S 3E5, Canada.

ACS biomaterials science & engineering
|March 6, 2026
PubMed
概括

这项研究展示了一种使用水凝和特定联体释放抗体来控制蛋白质输送的新方法. 这种亲和控制释放策略可提供可调节的治疗抗体输送.

关键词:
亲和关系链接.抗体是一种抗体.这是bevacizumab的治疗方法.有控制释放的释放.这种水凝是水凝.提供蛋白质的蛋白质输送.

更多相关视频

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

8.3K
Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition
09:06

Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition

Published on: December 23, 2016

22.5K

相关实验视频

Last Updated: Mar 7, 2026

Activated Cross-linked Agarose for the Rapid Development of Affinity Chromatography Resins - Antibody Capture as a Case Study
07:53

Activated Cross-linked Agarose for the Rapid Development of Affinity Chromatography Resins - Antibody Capture as a Case Study

Published on: August 16, 2019

9.9K
Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

8.3K
Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition
09:06

Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition

Published on: December 23, 2016

22.5K

科学领域:

  • 生物材料科学 生物材料科学
  • 药物输送系统 药物输送系统
  • 蛋白质工程是指蛋白质的工程.

背景情况:

  • 从水凝系统中控制释放治疗性蛋白质,特别是抗体,对于有效治疗至关重要.
  • 利用非共价相互作用为亲和控制的蛋白质递送提供了一个多功能平台.

研究的目的:

  • 开发和评估一种新的策略,利用亲和相互作用从水凝中控制释放原生抗体.
  • 为了设计针对人类IgG1的Fc区域的酸连体,以便在水凝内固定.

主要方法:

  • 为人类IgG1.1的Fc区域设计了两个具有不同亲和力的Fc结合配体 (FcL1和FcLPEG) (KD).
  • 在化学交叉连接的氨酸-氧化物水凝和物理交叉连接的氨酸-甲基纤维素水凝内的固定连接物.
  • 研究了从水凝系统中释放治疗抗体 (贝瓦西祖马布,阿达利穆马布) 的释放动力学.

主要成果:

  • 控制释放的生物活性贝瓦齐祖马布使用更高亲和度的FcL1连接体在氨酸-氧胺水凝中实现.
  • 较低亲和度的FcLPEG连接体没有促进受控释放.
  • 在7天的时间内,在氨酸-甲基纤维素水凝系统中,可调节的释放多个IgG1抗体被证明.

结论:

  • 开发的亲和控制释放策略广泛适用于调整水凝的抗体输送.
  • 这种方法可以精确控制治疗抗体的释放,从而提高其潜在的临床效用.